Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / India

Zydus Cadila To Take Stake In Simayla

June 2008 | Company News Alert

Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Ranbaxy Enters Yemen

Companies / India Indian generics multinational Ranbaxy Laboratories has entered Yemen's pharmaceutical market through a tie up with Yemen's National Trading Company (Natco). The deal will see Natco market a number of...
May 2008
India's IBPL To Launch Oncology Biotech Products

Companies / India Demonstrating faith in the Gulf states' appetite for novel drugs, India's Intas Biopharmaceuticals (IBPL) is to register itself in the Gulf Co-operation Council (GCC) region. IBPL is initially planning...
February 2008
Trade With India Set To Boom

Companies / India South Africa-India bilateral trade is set for strong growth according to the Federation of Indian Chambers of Commerce and Industry (FICCI). Overall trade is expected to reach US$12bn by 2010 - triple...
October 2007
Ranbaxy Expands South African Footprint

Companies / India Indian drugmaker Ranbaxy has expanded its presence in the South African pharmaceuticals market after completing the purchase of local producer Be-Tabs Pharmaceuticals in a deal worth ZAR500mn (US$72.17mn)....
May 2007
Indian Drugmakers Target East Africa

Companies / India Indian drugmaker Plethico Pharmaceuticals is planning to invest KES1.42bn (US$20mn) in a new manufacturing facility in Kenya. The factory is scheduled to begin operations by the end of the year and will...
April 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS